Researchers at Cincinnati Children’s Hospital Medical Center, working in partnership with Roche, have created a next-generation human liver organoid microarray platform designed to predict which medications might trigger harmful immune responses…
Continue Reading
News Source: www.sciencedaily.com

Leave a Reply